Skip to content

06978.HK

Immunotech Biopharm Ltd

HKSE · Healthcare · Biotechnology · CN

HKD 0.40
+0.00%
Ask drillr
  • Aug 23, 2026, 14:06 UTC

    Yongtai Biological (06978.HK) reported interim results for the six months ended June 2026, with other income of RMB 12.6 million, down 3.4% year-on-year, and a narrowed net loss of RMB 69.87 million from RMB 129 million a year earlier, with a loss per share of RMB 0.11, and no dividend declared.